Literature DB >> 30028980

Surgical Treatment of Acute Thoracic Stent Graft Occlusion.

Omayra C D Liesdek1, Kirolos A Jacob2, Aryan Vink3, Marijn A Vermeulen3, Constantijn E V B Hazenberg4, Willem J L Suyker2.   

Abstract

A 24-year-old man presented with acute onset paraplegia related to complete occlusion of a thoracic stent graft placed 2 years prior for repair of traumatic type B aortic dissection. Following emergency surgery comprising reestablishment of aortic flow by stent removal and aortic reconstruction, the paraplegia started to resolve partly, despite an estimated 5-hour interval of preoperative myelum ischemia. Anatomical characteristics of the stent graft placement appear to have played a role in causing this rare complication. Six months later, the patient could walk again with a stick. This case shows that early intervention in cases of full paraplegia may be considered.
Copyright © 2019 The Society of Thoracic Surgeons. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2018        PMID: 30028980     DOI: 10.1016/j.athoracsur.2018.05.099

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  3 in total

1.  Intragraft Obstructive Thrombus Two Years After Endovascular Repair of Traumatic Aortic Injury: A Case Report and Review of the Literature.

Authors:  E Beijer; V P W Scholtes; M Truijers; J H Nederhoed; K K Yeung; J D Blankensteijn
Journal:  EJVES Vasc Forum       Date:  2021-11-09

2.  Late Stent Thrombosis in a Patient with Endovascular Aortic Repair for Blunt Thoracic Aortic Injury.

Authors:  Michael H Chiu; Youri Kaitoukov; Amanda Roze des Ordons
Journal:  Case Rep Vasc Med       Date:  2022-02-14

3.  Blunt thoracic aortic injury and TEVAR: long-term outcomes and health-related quality of life.

Authors:  Dennis Hundersmarck; Quirine M J van der Vliet; Lotte M Winterink; Luke P H Leenen; Joost A van Herwaarden; Constantijn E V B Hazenberg; Falco Hietbrink
Journal:  Eur J Trauma Emerg Surg       Date:  2020-07-06       Impact factor: 2.374

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.